isradipine has been researched along with Neoplasms in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyashita, Y | 1 |
| Peterson, D | 1 |
| Rees, JM | 1 |
| Flynn, JT | 1 |
1 other study available for isradipine and Neoplasms
| Article | Year |
|---|---|
Isradipine for treatment of acute hypertension in hospitalized children and adolescents.
Topics: Acute Disease; Adolescent; Age Factors; Blood Pressure; Calcium Channel Blockers; Child; Child, Pres | 2010 |